Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1152749-21-7

morpholino(1H-pyrazol-4-yl)methanone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1152749-21-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1152749-21-7 Structure

  • Basic information

    1. Product Name: morpholino(1H-pyrazol-4-yl)methanone
    2. Synonyms: morpholino(1H-pyrazol-4-yl)methanone
    3. CAS NO:1152749-21-7
    4. Molecular Formula:
    5. Molecular Weight: 181.194
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1152749-21-7.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: morpholino(1H-pyrazol-4-yl)methanone(CAS DataBase Reference)
    10. NIST Chemistry Reference: morpholino(1H-pyrazol-4-yl)methanone(1152749-21-7)
    11. EPA Substance Registry System: morpholino(1H-pyrazol-4-yl)methanone(1152749-21-7)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1152749-21-7(Hazardous Substances Data)

1152749-21-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1152749-21-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,2,7,4 and 9 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1152749-21:
(9*1)+(8*1)+(7*5)+(6*2)+(5*7)+(4*4)+(3*9)+(2*2)+(1*1)=147
147 % 10 = 7
So 1152749-21-7 is a valid CAS Registry Number.

1152749-21-7Relevant articles and documents

METHOD OF PRODUCING CRYSTAL OF [1-(4-{3-[(2R)-2-METHYLPYRROLIDIN-1-YL]PROPOXY}PHENYL)-1H-PYRAZOL-4-YL](MORPHOLIN-4-YL)METHANONE

-

Paragraph 0216-0218, (2019/08/08)

PROBLEM TO BE SOLVED: To provide a novel method of producing a crystal of [1-(4-{3-[(2R)-2-methylpyrrolidin-1-yl]propoxy}phenyl)-1H-pyrazol-4-yl](morpholin-4-yl)methanone, which exhibits H3 receptor antagonism. SOLUTION: The invention provides a method of producing a crystal of a compound represented by formula [1] in the figure, which is crystallized using an ether based solvent. (X1 is methanesulfonyloxy, trifluoromethanesulfonyloxy, or p-toluenesulfonyloxy; and X2 is a halogen atom.) SELECTED DRAWING: Figure 9 COPYRIGHT: (C)2019,JPOandINPIT

PYRAZOLE COMPOUNDS AND METHODS OF MAKING AND USING SAME

-

Paragraph 00270, (2017/07/14)

Provided herein are pyrazole compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL and/or FAAH. Furthermore, the subject compounds and compositions are useful for the treatment of, for example, pain.

PHENYLPYRAZOLE DERIVATIVES

-

Page/Page column 27-28, (2010/09/05)

The present invention provides a prophylactic or therapeutic agent for dementia, Alzheimer's disease, attention-deficit hyperactivity disorder, schizophrenia, eating disorders, obesity, diabetes, hyperlipidemia, sleep disorders, narcolepsy, sleep apnea sy

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1152749-21-7